Determine the necessary mass, volume, or concentration for preparing a solution.
Enibarcimab (anti-Adrenomedullin) (Ab177847) - SEC
The purity of Enibarcimab (anti-Adrenomedullin) (Ab177847) is more than 95% verified by HPLC.
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
Ab177847-100μg | 100μg | In stock | $109.90 | |
Ab177847-1mg | 1mg | In stock | $519.90 | |
Ab177847-5mg | 5mg | In stock | $1,399.90 | |
Ab177847-10mg | 10mg | Available within 8-12 weeks(?) Production requires sourcing of materials. We appreciate your patience and understanding. | $2,239.90 |
Purity>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG1; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated
Product Name | Enibarcimab (anti-Adrenomedullin) - Primary antibody, specific to ADM, >95%, high purity, Human IgG1 |
---|---|
Specifications & Purity | ExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot |
Host species | Human |
Specificity | ADM |
Conjugation | Unconjugated |
Grade | Azide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated |
Action Type | STABILISER |
Mechanism of action | STABILISER of ADM stabiliser |
Product Description | Enibarcimab (anti-Adrenomedullin) is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research. |
Isotype | Human IgG1 |
---|---|
Light Chain Type | kappa |
SDS-PAGE | 26.3 kDa (Light Chain) & 53.6 kDa (Heavy Chain), under reducing conditions; 196.6 kDa, under non-reducing conditions. |
Purification Method | Protein A purified |
Purity | >95% |
Form | Liquid |
Concentration | Lot by Lot |
Storage Temp | Store at -80°C,Avoid repeated freezing and thawing |
Shipped In | Ice chest + Ice pads |
Stability And Storage | Store at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle. |
CAS | 2305638-98-4 |
Enibarcimab (anti-Adrenomedullin) (Ab177847) - SEC
The purity of Enibarcimab (anti-Adrenomedullin) (Ab177847) is more than 95% verified by HPLC.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Enter Lot Number to search for COA:
Find and download the COA for your product by matching the lot number on the packaging.
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
ZJ24F0303117 | Certificate of Analysis | Mar 12, 2024 | Ab177847 |
ZJ24F0303116 | Certificate of Analysis | Mar 12, 2024 | Ab177847 |
ZJ24F0303115 | Certificate of Analysis | Mar 12, 2024 | Ab177847 |
1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, Eto T. (1993) Adrenomedullin: a novel hypotensive peptide isolated from human pheochromocytoma.. Biochem Biophys Res Commun, 192 (2): (553-60). [PMID:8387282] [10.1021/op500134e] |
2. Kitamura, K K and 5 more authors.. (1993) Cloning and characterization of cDNA encoding a precursor for human adrenomedullin.. Biochemical and biophysical research communications, (30): [PMID:7688224] |
3. Ishimitsu, T T and 7 more authors.. (1994) Genomic structure of human adrenomedullin gene.. Biochemical and biophysical research communications, (30): [PMID:8074714] |
4. and Samson, W K WK.. (1998) Proadrenomedullin-derived peptides.. Frontiers in neuroendocrinology, [PMID:9578982] |
5. Champion, H C HC, Nussdorfer, G G GG and Kadowitz, P J PJ.. (1999) Structure-activity relationships of adrenomedullin in the circulation and adrenal gland.. Regulatory peptides, (30): [PMID:10588445] |
6. Lucyk, S S, Taha, H H, Yamamoto, H H, Miskolzie, M M and Kotovych, G G.. (2006) NMR conformational analysis of proadrenomedullin N-terminal 20 peptide, a proangiogenic factor involved in tumor growth.. Biopolymers, [PMID:16315141] |